Immuneering (IMRX) Shares Outstanding (Diluted) (2020 - 2026)
Immuneering's Weighted Average Shares Outstanding (Diluted) was 64.71 million in Q3 2026, up 63.1% from 39.67 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025, Weighted Average Shares Outstanding (Diluted) at Immuneering came in at 44.01 million, up 46.8% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has now increased for five consecutive years, with a five-year compound annual growth rate of 54.8% (FY2020 to FY2025).
- In earlier years, Weighted Average Shares Outstanding (Diluted) was 29.98 million in FY2024 (+5.5%), 28.42 million in FY2023 (+7.7%), 26.39 million in FY2022 (+93.8%) and 13.61 million in FY2021 (+175.0%).
- The Q3 2026 figure marks the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q2 2020.
- Compared with a year earlier, Weighted Average Shares Outstanding (Diluted) has increased for 22 straight quarters, with growth averaging 44.1% over the last eight quarters.
- Over the past five years, the year-over-year growth in Weighted Average Shares Outstanding (Diluted) ranged from 0.3% (Q1 2023) to 432.6% (Q2 2022).
- Per Business Quant data, IMRX's Weighted Average Shares Outstanding (Diluted) in the three quarters before Q3 2026 was 64.7 million (Q2 2026), 64.66 million (Q1 2026) and 44.01 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Immuneering | 249.34 Mn | -375.49 Mn | - | 64.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 64.71 Mn |
| Jun 30, 2026 | 64.70 Mn |
| Mar 31, 2026 | 64.66 Mn |
| Dec 31, 2025 | 44.01 Mn |
| Sep 30, 2025 | 39.67 Mn |
| Jun 30, 2025 | 35.99 Mn |
| Mar 31, 2025 | 35.53 Mn |
| Dec 31, 2024 | 29.98 Mn |
| Sep 30, 2024 | 29.84 Mn |
| Jun 30, 2024 | 29.65 Mn |
| Mar 31, 2024 | 29.37 Mn |
| Dec 31, 2023 | 28.42 Mn |
| Sep 30, 2023 | 29.27 Mn |
| Jun 30, 2023 | 28.65 Mn |
| Mar 31, 2023 | 26.44 Mn |
| Dec 31, 2022 | 26.39 Mn |
| Sep 30, 2022 | 26.39 Mn |
| Jun 30, 2022 | 26.39 Mn |
| Mar 31, 2022 | 26.36 Mn |
| Dec 31, 2021 | 13.61 Mn |
API Access
Immuneering Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();